BioCryst Pharmaceuticals, Inc

(NASDAQ:BCRX)

Latest On BioCryst Pharmaceuticals, Inc (BCRX):

Date/Time Type Description Signal Details
2023-05-31 17:21 ESTNewsBioCryst Pharmaceuticals: An Updated ViewN/A
2023-05-03 21:24 ESTNewsBioCryst Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-03 21:24 ESTNewsBioCryst Pharmaceuticals, Inc. (BCRX) Q1 2023 Earnings Call TranscriptN/A
2023-05-03 21:24 ESTNewsBioCryst gains 14% most since February after Q1 2023 resultsN/A
2023-05-03 08:06 ESTNewsBioCryst Pharmaceuticals GAAP EPS of -$0.28 beats by $0.03, revenue of $68.78M misses by $2.66MN/A
2023-04-18 20:53 ESTNewsBioCryst secures five-year credit facilityN/A
2023-04-12 14:45 ESTNewsThe Big Short: 5 Stocks At Risk With High Short InterestN/A
2023-03-17 06:01 ESTNewsBioCryst's Commercialization Of Orladeyo: Risks Materializing, A Shorting OpportunityN/A
2023-03-08 22:50 ESTNewsBioCryst: Good Candidate For Buyout, But Not For Anything ElseN/A
2023-03-08 22:50 ESTNewsBioCryst wins Canadian nod for Orladeyo reimbursementN/A
2023-03-02 13:37 ESTNewsBioCryst Pharmaceuticals (BCRX) Presents At J.P. MORGAN HEALTHCARE CONFERENCEN/A
2023-02-22 23:25 ESTNewsBioCryst adds 13% to rebound as Needham upgrades; says selloff overdoneN/A
2023-02-22 10:26 ESTNewsBioCryst Is Not Currently Uncovering The Full Value Of ORLADEYON/A
2023-02-21 21:57 ESTNewsBioCryst at nine-month low as Q4 bottom-line disappointsN/A
2023-02-21 21:57 ESTNewsBioCryst Pharmaceuticals, Inc. (BCRX) Q4 2022 Earnings Call TranscriptN/A
2023-02-21 21:57 ESTNewsBioCryst Pharmaceuticals, Inc. 2022 Q4 - Results - Earnings Call PresentationN/A
2023-02-21 08:13 ESTNewsBioCryst Pharmaceuticals Non-GAAP EPS of -$0.38 misses by $0.18, revenue of $79.5M beats by $5.32MN/A
2023-02-20 19:27 ESTNewsBioCryst Pharmaceuticals Q4 2022 Earnings PreviewN/A
2023-02-04 07:22 ESTNewsBioCryst Pharmaceuticals: An Overview Of Orladeyo For Hereditary AngioedemaN/A
2023-01-23 12:51 ESTNewsBioCryst teams up with Swixx to sell Orladeyo in Central, Eastern EuropeN/A
2023-01-09 13:46 ESTNewsBioCryst drops as sales for hereditary angioedema therapy lag forecastsN/A
2022-12-21 02:03 ESTNewsBioCryst Pharmaceuticals: More Aggressive Growth For OrladeyoN/A
2022-12-16 00:24 ESTNewsBioCryst drops on plans to discontinue oral Factor D inhibitorN/A
2022-12-16 00:22 ESTNewsBioCryst strategic interest likely to rise after oral Factor D inhibitor decision - CowenN/A
2022-12-06 15:56 ESTNewsBad flu season turned even worse around Thanksgiving - CDCN/A
2022-11-15 15:48 ESTNewsBioCryst Pharmaceuticals (BCRX) Investor Presentation -SlideshowN/A
2022-11-04 16:23 ESTNewsFewer Americans have received the flu shot compared to same time last year - CDCN/A
2022-11-02 13:59 ESTNewsBioCryst rebounds as Evercore ISI upgrades after earnings day selloffN/A
2022-11-01 22:53 ESTNewsBioCryst Pharmaceuticals reports Q3 earnings beat; updates FY22 guidanceN/A
2022-11-01 22:53 ESTNewsBioCryst Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-01 22:53 ESTNewsBioCryst Pharmaceuticals, Inc. (BCRX) Q3 2022 Earnings Call TranscriptN/A
2022-11-01 22:52 ESTNewsBioCryst falls 11% despite Q3 beat (update)N/A
2022-10-28 13:05 ESTNewsFlu season off to a strong and early start, CDC data findsN/A
2022-10-11 12:49 ESTNewsBioCryst Pharmaceuticals: Working To Increase Market Presence Of OrladeyoN/A
2022-09-14 19:02 ESTNewsBioCryst Pharmaceuticals promotes Sheridan to development chiefN/A
2022-08-31 10:00 ESTNewsBioCryst wins FDA’s Orphan Drug status for bone disorder therapyN/A
2022-08-26 17:59 ESTNewsBioCryst's BCX9930 for rare kidney disorder shows promise in early-stage studyN/A
2022-08-25 09:20 ESTNewsBioCryst to supply 10K doses of influenza drug Rapivab to US for ~$7MN/A
2022-08-18 07:38 ESTNewsBioCryst Orladeyo gets approval in Saudi Arabia to prevent hereditary angioedema attacksN/A
2022-08-04 23:49 ESTNewsBioCryst Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-04 23:49 ESTNewsBioCryst adds 16% as FDA lifts clinical hold on kidney disease programN/A
2022-08-04 23:48 ESTNewsBioCryst Pharmaceuticals, Inc. (BCRX) CEO Jon Stonehouse on Q2 Results - Earnings Call TranscriptN/A
2022-08-04 08:14 ESTNewsBioCryst Pharmaceuticals GAAP EPS of -$0.32 beats by $0.03, revenue of $65.53M beats by $1.7MN/A
2022-08-03 17:46 ESTNewsBioCryst Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-07-26 00:41 ESTNewsBioCryst Pharmaceuticals: Waiting For ClarityN/A
2022-06-24 22:18 ESTNewsBioCryst: A Prudent DiversificationN/A
2022-06-19 14:18 ESTNewsBioCryst Pharmaceuticals (BCRX) Investor Presentation - SlideshowN/A
2022-06-10 13:01 ESTNewsBioCryst collaborates with Pint Pharma to sell Orladeyo in Latin AmericaN/A
2022-06-08 15:55 ESTNewsBioCryst nabs FDA’s Fast Track status for candidate targeting rare bone forming disorderN/A
2022-06-08 00:50 ESTNewsBioCryst Orladeyo gets approval in Switzerland to prevent hereditary angioedema attacksN/A

About BioCryst Pharmaceuticals, Inc (BCRX):

BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor, for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and Mundesine, an oral purine nucleoside phosphorylase inhibitor for peripheral T-cell lymphoma. It is also developing ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema; BCX9930, an oral factor D inhibitor, which is in Phase I clinical trials for mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitors that is in Phase I clinical trials to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trials to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with U.S. Department of Health and Human Services; National Institute of Allergy and Infectious Diseases; Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.

BCRX Quotes by TradingView

See Advanced Chart

General

  • Name BioCryst Pharmaceuticals, Inc
  • Symbol BCRX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 246
  • Fiscal Year EndDecember
  • IPO Date1994-03-03
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.biocryst.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 31.41
  • Price/Book (Most Recent Quarter) 56.59
  • Enterprise Value Revenue 103.35
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.05
  • Next Year EPS Estimate -$0.73
  • Next Quarter EPS Estimate -$0.28
  • Operating Margin -981%
  • Return on Assets -43%
  • Return on Equity -1925%
  • Revenue 17.81 million
  • Earnings Per Share -$1.15
  • Revenue Per Share $0.11
  • Gross Profit -106828000
  • Quarterly Earnings Growth -89.9%
View More

Highlights

  • Market Capitalization 2.25 billion
  • EBITDA -106253000
  • PE Ratio -12.32
  • PEG Ratio -0.28
  • Analyst Target Price $13.78
  • Book Value Per Share $0.19
View More

Share Statistics

  • Shares Outstanding 177.52 million
  • Shares Float 162.86 million
  • % Held by Insiders 85%
  • % Held by Institutions 73.95%
  • Shares Short 28.92 million
  • Shares Short Prior Month 28.86 million
  • Short Ratio 3.27
  • Short % of Float 18%
  • Short % of Shares Outstanding 16%
View More

Technicals

  • Beta 2.82
  • 52 Week High $13.93
  • 52 Week Low $1.78
  • 50 Day Moving Average 11.07
  • 200 Day Moving Average 6.8
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

BioCryst Pharmaceuticals, Inc (BCRX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

BioCryst Pharmaceuticals, Inc (BCRX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A-$0.34-$0.24-42.56%
2020-09-302020-11-05$N/A-$0.26-$0.26-1.13%
2020-06-302020-08-06$N/A-$0.24-$0.254.53%
2020-03-312020-05-06$N/A-$0.24-$0.240.62%
2019-12-312020-03-05$39.73 million-$0.02-$0.2792.51%
2019-09-302019-11-06$1.78 million-$0.34-$0.31-8.11%
2019-06-302019-08-06$1.45 million-$0.34-$0.32-7.12%
2019-03-312019-05-08$5.89 million-$0.28-$0.28-1.82%
2018-12-312019-03-04$2.73 million-$0.25-$0.24-2.75%
2018-09-302018-11-06$1.45 million-$0.28-$0.26-7.94%
2018-06-302018-08-07$12.49 million-$0.19-$0.2421.26%
2018-03-312018-05-08$3.98 million-$0.26-$0.19-35.06%
2017-12-312018-02-27$3.89 million-$0.20-$0.16-26.5%
2017-09-302017-11-07$8.76 million-$0.18-$0.182.39%
2017-06-302017-08-07$3.1 million-$0.21-$0.19-10.53%
2017-03-312017-05-04$9.44 million-$0.19-$0.19-2.15%
2016-12-312017-02-27$8.98 million-$0.06-$0.2474.82%
2016-09-302016-11-07$7.76 million-$0.16-$0.2637.84%
2016-06-302016-08-04$4.79 million-$0.22-$0.2615.25%
2016-03-312016-05-05$4.82 million-$0.31-$0.23-34.32%
2015-12-312016-02-23$4.6 million-$0.25-$0.250.68%
2015-09-302015-11-05$10.99 million-$0.20-$0.200%
2015-06-302015-08-07$25.84 million$0.06-$0.22127.27%
2015-03-312015-05-08$6.83 million-$0.21-$0.2516%
2014-12-312015-02-18$5.45 million-$0.16-$0.2123.81%
2014-09-302014-11-06$3.24 million-$0.12-$0.2040%
2014-06-302014-08-05$1.47 million-$0.23-$0.19-21.05%
2014-03-312014-05-08$3.46 million-$0.17-$0.170%
2013-12-312014-02-26$10.57 million-$0.09-$0.090%
2013-09-302013-11-05$2.39 million-$0.14-$0.11-27.27%
2013-06-302013-08-08$821000-$0.23-$0.13-76.92%
2013-03-312013-05-07$3.55 million-$0.09-$0.1540%
2012-12-312013-02-19$4.1 million-$0.18-$0.16-12.5%
2012-09-302012-11-08$5.76 million-$0.19-$0.2524%
2012-06-302012-08-02$4.21 million-$0.25-$0.263.85%
2012-03-312012-05-07$12.22 million-$0.13-$0.2650%
2011-12-312012-02-16$5.22 million-$0.29-$0.28-3.57%
2011-09-302011-11-02$5.25 million-$0.32-$0.26-23.08%
2011-06-302011-08-04$3.74 million-$0.36-$0.25-44%
2011-03-312011-05-04$5.44 million-$0.29-$0.20-45%
2010-12-312011-02-10$16.69 million-$0.20-$0.214.76%
2010-09-302010-10-28$12 million-$0.24-$0.17-41.18%
2010-06-302010-08-05$7.62 million-$0.23-$0.22-4.55%
2010-03-312010-04-28$26.07 million-$0.06-$0.1662.5%
2009-12-312010-02-04$54.9 million$0.35$0.09288.89%
2009-09-302009-10-29$10.55 million-$0.28-$0.22-27.27%
2009-06-302009-07-30$4.79 million-$0.23-$0.258%
2009-03-312009-05-08$4.36 million-$0.24-$0.2814.29%
2008-12-312009-02-06$34.24 million$0.26-$0.22218.18%
2008-09-302008-10-31$8.89 million-$0.24-$0.240%
2008-06-302008-08-07$2.66 million-$0.33-$0.20-65%
2008-03-312008-05-08$10.77 million-$0.34-$0.18-88.89%
2007-12-312008-03-04$28.17 million-$0.06-$0.3984.62%
2007-09-302007-11-08$20.46 million-$0.32-$0.28-14.29%
2007-06-302007-08-09$13.44 million-$0.24-$0.3327.27%
2007-03-312007-05-09$9.16 million-$0.30-$0.27-11.11%
2006-12-312007-02-07$2.09 million-$0.34-$0.5032%
2006-09-302006-11-08$1.79 million-$0.53-$0.41-29.27%
2006-06-302006-08-09$1.56 million-$0.35-$0.29-20.69%
2006-03-312006-04-27$771000-$0.27-$0.24-12.5%
2005-12-312006-02-08$21000-$0.27-$0.296.9%
2005-09-302005-10-26$32000-$0.29-$0.24-20.83%
2005-06-302005-08-03$58000-$0.22-$0.2512%
2005-03-312005-04-21$41000-$0.24-$0.240%
2004-12-312005-02-02$178000-$0.24-$0.267.69%
2004-09-302004-10-20$116000-$0.24-$0.240%
2004-06-302004-07-21$43000-$0.23-$0.2817.86%
2004-03-312004-04-21$N/A-$0.28-$0.22-27.27%
2003-12-312004-02-04$654000-$0.18-$0.2010%
2003-09-302003-10-20$N/A-$0.19
2003-06-302003-07-30$N/A-$0.18
2003-03-312003-03-31$N/A-$0.16
2002-12-312002-12-31$N/A-$0.16
2002-09-302002-09-30$N/A-$0.19
2002-06-302002-06-30$N/A-$0.29
2002-03-312002-03-31$N/A-$0.32
2001-12-312002-01-30$4.34 million-$0.28-$0.14-100%
2001-09-302001-10-24$3.4 million$0.02-$0.13115.38%
2001-06-302001-07-25$3.64 million-$0.08-$0.1233.33%
2001-03-312001-04-25$703000-$0.08-$0.1127.27%
2000-12-312001-02-01$803000-$0.11-$0.128.33%
2000-09-302000-10-25$763000-$0.09-$0.1118.18%
2000-06-302000-07-26$1.19 million-$0.11-$0.128.33%
2000-03-312000-04-26$564000$0.10-$0.04350%
1999-12-312000-02-02-$0.03-$0.01-200%
1999-09-301999-10-21-$0.15-$0.1816.67%
1999-06-301999-07-21-$0.02-$0.0875%
1999-03-311999-03-31-$0.16
1998-12-311999-01-27-$0.10-$0.2458.33%
1998-09-301998-10-28$0.19$0.185.56%
1998-06-301998-07-22-$0.21-$0.2516%
1998-03-311998-03-31-$0.22
1997-12-311998-02-03-$0.21-$0.238.7%
1997-03-311997-04-28-$0.23-$0.12-91.67%
1996-12-311997-02-10-$0.15-$0.2128.57%
1996-09-301996-10-29-$0.23-$0.2817.86%
1996-06-301996-07-25-$0.11$0.05-320%
1996-03-311996-04-24-$0.20-$0.2623.08%
1995-12-311996-01-29-$0.23-$0.2611.54%
1995-09-301995-10-17-$0.20-$0.2313.04%
1995-06-301995-07-25-$0.18-$0.3345.45%
1995-03-311995-04-28-$0.37-$0.31-19.35%
1994-12-311995-01-31-$0.24-$0.267.69%
1994-09-301994-10-26-$0.22-$0.3129.03%
1994-06-301994-08-02-$0.25-$0.3324.24%

BioCryst Pharmaceuticals, Inc (BCRX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

BioCryst Pharmaceuticals, Inc (BCRX) Chart:

BioCryst Pharmaceuticals, Inc (BCRX) News:

Below you will find a list of latest news for BioCryst Pharmaceuticals, Inc (BCRX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

BioCryst Pharmaceuticals, Inc (BCRX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-06-2010CALL0 0893.56TRUE00
2025-06-2028.4CALL0 1190.89TRUE00
2025-06-2034.8CALL0 8254.54TRUE00
2025-06-2046.5CALL0 3349.2TRUE00
2025-06-2053.1CALL0 16171.2TRUE00
2025-06-2064.23CALL0 121133.27TRUE00
2025-06-2073.37CALL0 48136.06TRUE00
2025-06-2082.25CALL0 297688.01TRUE00
2025-06-2091.4CALL9 35346.01TRUE0.050.04
2025-06-20100.6CALL6 278636.27TRUE-0.1-0.14
2025-06-20110.25CALL9 98141.35FALSE-0.02-0.07
2025-06-20120.06CALL1101 62138.98FALSE-0.09-0.6
2025-06-20130.05CALL0 21670.8FALSE00
2025-06-20140.06CALL0 18284.78FALSE00
2025-06-20150.03CALL0 993.21FALSE00
2025-06-20160CALL0 0134.94FALSE00
2025-06-20170CALL0 0146.08FALSE00
2025-06-20180CALL0 0156.26FALSE00
2025-06-20190CALL0 0165.65FALSE00
2025-06-20200CALL0 0174.34FALSE00
2025-06-20210CALL0 0182.45FALSE00
2025-06-2010PUT0 0736.03FALSE00
2025-06-2020PUT0 0482.91FALSE00
2025-06-2030PUT0 0363.98FALSE00
2025-06-2040PUT0 0286.42FALSE00
2025-06-2050PUT0 0228.6FALSE00
2025-06-2060.2PUT0 16182.03FALSE00
2025-06-2070.04PUT0 69142.47FALSE00
2025-06-2080.05PUT1 10856.34FALSE0.050
2025-06-2090.1PUT1 29442.67FALSE0.10
2025-06-20100.4PUT161 149842.83FALSE00
2025-06-20111.2PUT0 2850.42TRUE00
2025-06-20121.88PUT0 1135.3TRUE00
2025-06-20134.62PUT0 448.83TRUE00
2025-06-20146.35PUT0 098.57TRUE00
2025-06-20154.75PUT0 0168.4TRUE00
2025-06-20160PUT0 0124.13TRUE00
2025-06-20170PUT0 0190.07TRUE00
2025-06-20180PUT0 0186.49TRUE00
2025-06-20190PUT0 0128.5TRUE00
2025-06-20200PUT0 0231.46TRUE00
2025-06-20210PUT0 0235.76TRUE00
2025-07-1820CALL0 0247.45TRUE00
2025-07-1830CALL0 0235.27TRUE00
2025-07-1840CALL0 0223.03TRUE00
2025-07-1850CALL0 0123.35TRUE00
2025-07-1860CALL0 0289.78TRUE00
2025-07-1870CALL0 0273TRUE00
2025-07-1880CALL0 050.57TRUE00
2025-07-1890CALL0 020.58TRUE00
2025-07-18100.82CALL6 039.32TRUE0.820
2025-07-18110CALL0 045.71FALSE00
2025-07-18120CALL0 039.84FALSE00
2025-07-18130CALL0 068.5FALSE00
2025-07-18140CALL0 080.13FALSE00
2025-07-18150CALL0 074.19FALSE00
2025-07-18160CALL0 079.71FALSE00
2025-07-18170CALL0 0107.73FALSE00
2025-07-18180CALL0 0115.28FALSE00
2025-07-1820PUT0 0358.31FALSE00
2025-07-1830PUT0 0270.16FALSE00
2025-07-1840PUT0 0212.7FALSE00
2025-07-1850PUT0 0169.86FALSE00
2025-07-1860PUT0 0135.38FALSE00
2025-07-1870PUT0 0116.65FALSE00
2025-07-1880PUT0 050.37FALSE00
2025-07-1890PUT0 041.64FALSE00
2025-07-18100PUT0 043.28FALSE00
2025-07-18110PUT0 043.28TRUE00
2025-07-18120PUT0 086.38TRUE00
2025-07-18130PUT0 059.54TRUE00
2025-07-18140PUT0 083.55TRUE00
2025-07-18150PUT0 0167.66TRUE00
2025-07-18160PUT0 0172.48TRUE00
2025-07-18170PUT0 0112.46TRUE00
2025-07-18180PUT0 084.09TRUE00
2025-09-1910CALL0 00TRUE00
2025-09-1928CALL0 27649.87TRUE00
2025-09-1930CALL0 0162.12TRUE00
2025-09-1940CALL0 0172.97TRUE00
2025-09-1950CALL0 0178.92TRUE00
2025-09-1961.8CALL0 2396.04TRUE00
2025-09-1973.5CALL0 6061.49TRUE00
2025-09-1982.55CALL10 327244.43TRUE2.550
2025-09-1991.85CALL1 35545.91TRUE0.150.09
2025-09-19101.25CALL33 50044.65TRUE-0.03-0.02
2025-09-19110.79CALL0 14142.65FALSE00
2025-09-19120.57CALL1 33146.76FALSE0.570
2025-09-19130.32CALL0 4341.93FALSE00
2025-09-19140.25CALL0 1056.99FALSE00
2025-09-19150.15CALL0 1947.63FALSE00
2025-09-19160.15CALL0 1069.31FALSE00
2025-09-19170CALL0 075.15FALSE00
2025-09-19180CALL0 080.49FALSE00
2025-09-19190CALL0 085.41FALSE00
2025-09-19200CALL0 089.97FALSE00
2025-09-19210CALL0 094.21FALSE00
2025-09-1910PUT0 0386.08FALSE00
2025-09-1920PUT0 0253.46FALSE00
2025-09-1930PUT0 0191.26FALSE00
2025-09-1940PUT0 0150.74FALSE00
2025-09-1950PUT0 0120.55FALSE00
2025-09-1960.7PUT0 1096.26FALSE00
2025-09-1970.85PUT0 10649.94FALSE00
2025-09-1980.3PUT0 4374.15FALSE00
2025-09-1990.5PUT0 3445.58FALSE00
2025-09-19100.86PUT8 8544.12FALSE-0.04-0.04
2025-09-19111.62PUT0 2416.86TRUE00
2025-09-19124.7PUT0 030.88TRUE00
2025-09-19136.6PUT0 034.09TRUE00
2025-09-19147.35PUT0 063.26TRUE00
2025-09-19157.1PUT0 2146.27TRUE00
2025-09-19160PUT0 070.67TRUE00
2025-09-19170PUT0 086.21TRUE00
2025-09-19180PUT0 075.18TRUE00
2025-09-19190PUT0 0130.98TRUE00
2025-09-19200PUT0 0102.89TRUE00
2025-09-19210PUT0 0150.95TRUE00
2025-12-1910CALL0 00TRUE00
2025-12-1920CALL0 0182.4TRUE00
2025-12-1930CALL0 0172.28TRUE00
2025-12-1940CALL0 0142.64TRUE00
2025-12-1950CALL0 0105.63TRUE00
2025-12-1960CALL0 089.84TRUE00
2025-12-1972.52CALL0 137.29TRUE00
2025-12-1983.02CALL0 3258.31TRUE00
2025-12-1991.97CALL0 2426.96TRUE00
2025-12-19101.6CALL0 3643.92TRUE00
2025-12-19111.27CALL0 9344.65FALSE00
2025-12-19121.2CALL0 2147.86FALSE00
2025-12-19130CALL0 051.27FALSE00
2025-12-19140.36CALL0 6160.88FALSE00
2025-12-19150.25CALL0 10043.58FALSE00
2025-12-19160CALL0 044.43FALSE00
2025-12-19170CALL0 048.61FALSE00
2025-12-19180CALL0 053.91FALSE00
2025-12-19190CALL0 064.26FALSE00
2025-12-19200CALL0 072.62FALSE00
2025-12-19210CALL0 070.99FALSE00
2025-12-1910PUT0 0295.29FALSE00
2025-12-1920PUT0 0193.97FALSE00
2025-12-1930PUT0 0146.53FALSE00
2025-12-1940PUT0 0160.77FALSE00
2025-12-1950PUT0 092.66FALSE00
2025-12-1960PUT0 053.29FALSE00
2025-12-1970PUT0 058.49FALSE00
2025-12-1980PUT0 043.32FALSE00
2025-12-1991.25PUT0 333.72FALSE00
2025-12-19101.25PUT0 2165.51FALSE00
2025-12-19111.73PUT0 139.22TRUE00
2025-12-19120PUT0 035.52TRUE00
2025-12-19130PUT0 041.86TRUE00
2025-12-19140PUT0 040.95TRUE00
2025-12-19150PUT0 040.19TRUE00
2025-12-19160PUT0 065.98TRUE00
2025-12-19170PUT0 062.31TRUE00
2025-12-19180PUT0 076.09TRUE00
2025-12-19190PUT0 096.26TRUE00
2025-12-19200PUT0 084.79TRUE00
2025-12-19210PUT0 073.15TRUE00
2026-01-1617.92CALL0 2216.42TRUE00
2026-01-1628.33CALL0 50141.13TRUE00
2026-01-1635.8CALL0 1475.53TRUE00
2026-01-1646.2CALL0 10265.75TRUE00
2026-01-1655.3CALL20 138174.14TRUE5.30
2026-01-1660CALL0 039.46TRUE00
2026-01-1673.5CALL0 41251.94TRUE00
2026-01-1683.97CALL0 20052TRUE00
2026-01-1692.34CALL0 39353.7TRUE00
2026-01-16101.75CALL3 634445.56TRUE1.750
2026-01-16111.2CALL0 30844.61FALSE00
2026-01-16120.85CALL0 118743.93FALSE00
2026-01-16130.5CALL0 12033.69FALSE00
2026-01-16140.45CALL77 041.62FALSE0.450
2026-01-16150.35CALL0 14242.94FALSE00
2026-01-16160CALL0 059.39FALSE00
2026-01-16170CALL0 044.12FALSE00
2026-01-16180CALL0 046.12FALSE00
2026-01-16190CALL0 047.62FALSE00
2026-01-16200CALL0 063.53FALSE00
2026-01-16210CALL0 066.59FALSE00
2026-01-1610PUT0 0278.31FALSE00
2026-01-1620.01PUT0 3182.84FALSE00
2026-01-1630.01PUT0 14138.18FALSE00
2026-01-1640PUT0 0109.1FALSE00
2026-01-1650.11PUT0 26966.78FALSE00
2026-01-1660.01PUT0 547.67FALSE00
2026-01-1670.01PUT0 469742.76FALSE00
2026-01-1680.51PUT0 139.82FALSE00
2026-01-1690.75PUT0 444.07FALSE00
2026-01-16101.27PUT21 24446.13FALSE1.270
2026-01-16112PUT0 4343.43TRUE00
2026-01-16122.22PUT0 2842.91TRUE00
2026-01-16130PUT0 040.09TRUE00
2026-01-16140PUT0 053.17TRUE00
2026-01-16155.1PUT0 364.62TRUE00
2026-01-16160PUT0 073.72TRUE00
2026-01-16170PUT0 082.31TRUE00
2026-01-16180PUT0 051.93TRUE00
2026-01-16190PUT0 070.55TRUE00
2026-01-16200PUT0 080.96TRUE00
2026-01-16210PUT0 073.03TRUE00
2027-01-1535.4CALL0 6089.3TRUE00
2027-01-1555.7CALL0 17258.24TRUE00
2027-01-1574.7CALL0 9751.88TRUE00
2027-01-15102.89CALL15 31548.7TRUE0.050.02
2027-01-15122CALL4 25645.1FALSE20
2027-01-15151CALL0 10843.73FALSE00
2027-01-15171.73CALL3 045.75FALSE1.730
2027-01-15200.47CALL10 041.36FALSE0.470
2027-01-1530.01PUT0 12151.5FALSE00
2027-01-1550.55PUT0 352.11FALSE00
2027-01-1570.74PUT0 3149.69FALSE00
2027-01-15102.05PUT0 544.75FALSE00
2027-01-15120PUT0 058.59TRUE00
2027-01-15157.4PUT0 130.23TRUE00
2027-01-15170PUT0 039.28TRUE00
2027-01-15200PUT0 094.33TRUE00

Latest BCRX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST62$9.355
Jun 13, 2022 7:59 PM EST55$9.355
Jun 13, 2022 7:59 PM EST25$9.355
Jun 13, 2022 7:59 PM EST10$9.355
Jun 13, 2022 7:59 PM EST1$9.355

BioCryst Pharmaceuticals, Inc (BCRX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465920072065/0001104659-20-072065-index.htm
2020-04-27UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/882796/000000000020003589/0000000000-20-003589-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000021545719003209/0000215457-19-003209-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000083423720004615/0000834237-20-004615-index.htm
2019-11-19SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000089914019000618/0000899140-19-000618-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000089914020000183/0000899140-20-000183-index.htm
2020-04-17SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000090266420001843/0000902664-20-001843-index.htm
2019-01-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000093041319000073/0000930413-19-000073-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000093247119004892/0000932471-19-004892-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465919008702/0001104659-19-008702-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465920018856/0001104659-20-018856-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465920021757/0001104659-20-021757-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465920021905/0001104659-20-021905-index.htm
2020-06-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465920072065/0001104659-20-072065-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218036067/0001127602-18-036067-index.htm
2018-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218036977/0001127602-18-036977-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037163/0001127602-18-037163-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037166/0001127602-18-037166-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037170/0001127602-18-037170-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037173/0001127602-18-037173-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037177/0001127602-18-037177-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037182/0001127602-18-037182-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219000701/0001127602-19-000701-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219000710/0001127602-19-000710-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219000720/0001127602-19-000720-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219000730/0001127602-19-000730-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219000736/0001127602-19-000736-index.htm
2019-01-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219001579/0001127602-19-001579-index.htm
2019-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219001582/0001127602-19-001582-index.htm
2019-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219002141/0001127602-19-002141-index.htm
2019-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219002367/0001127602-19-002367-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219002527/0001127602-19-002527-index.htm
2019-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219003053/0001127602-19-003053-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219003737/0001127602-19-003737-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219011361/0001127602-19-011361-index.htm
2019-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219014988/0001127602-19-014988-index.htm
2019-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219019143/0001127602-19-019143-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219019891/0001127602-19-019891-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020298/0001127602-19-020298-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020302/0001127602-19-020302-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020306/0001127602-19-020306-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020310/0001127602-19-020310-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020312/0001127602-19-020312-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020314/0001127602-19-020314-index.htm
2019-07-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219023817/0001127602-19-023817-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219023901/0001127602-19-023901-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219027858/0001127602-19-027858-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219027862/0001127602-19-027862-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219027867/0001127602-19-027867-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219027871/0001127602-19-027871-index.htm
2019-09-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219029010/0001127602-19-029010-index.htm
2019-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219029012/0001127602-19-029012-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033001/0001127602-19-033001-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033004/0001127602-19-033004-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033008/0001127602-19-033008-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033017/0001127602-19-033017-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033022/0001127602-19-033022-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033025/0001127602-19-033025-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033029/0001127602-19-033029-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033033/0001127602-19-033033-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033035/0001127602-19-033035-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219034162/0001127602-19-034162-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219034165/0001127602-19-034165-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219034168/0001127602-19-034168-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219034170/0001127602-19-034170-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035542/0001127602-19-035542-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035544/0001127602-19-035544-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035547/0001127602-19-035547-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035549/0001127602-19-035549-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035551/0001127602-19-035551-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035553/0001127602-19-035553-index.htm
2019-12-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035849/0001127602-19-035849-index.htm
2019-12-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035852/0001127602-19-035852-index.htm
2020-01-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220001879/0001127602-20-001879-index.htm
2020-01-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220001981/0001127602-20-001981-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006477/0001127602-20-006477-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006488/0001127602-20-006488-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006497/0001127602-20-006497-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006501/0001127602-20-006501-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006505/0001127602-20-006505-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006508/0001127602-20-006508-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007615/0001127602-20-007615-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007625/0001127602-20-007625-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007640/0001127602-20-007640-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007672/0001127602-20-007672-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007677/0001127602-20-007677-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007687/0001127602-20-007687-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009058/0001127602-20-009058-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009065/0001127602-20-009065-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009089/0001127602-20-009089-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009094/0001127602-20-009094-index.htm
2020-03-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009104/0001127602-20-009104-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009112/0001127602-20-009112-index.htm
2020-04-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220013457/0001127602-20-013457-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220015179/0001127602-20-015179-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016548/0001127602-20-016548-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016559/0001127602-20-016559-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016565/0001127602-20-016565-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016569/0001127602-20-016569-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016571/0001127602-20-016571-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016575/0001127602-20-016575-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016580/0001127602-20-016580-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016584/0001127602-20-016584-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016759/0001127602-20-016759-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220018704/0001127602-20-018704-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220018711/0001127602-20-018711-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220018715/0001127602-20-018715-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220018719/0001127602-20-018719-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220023449/0001127602-20-023449-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220024637/0001127602-20-024637-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220024642/0001127602-20-024642-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220024644/0001127602-20-024644-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220024646/0001127602-20-024646-index.htm
2019-11-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/882796/000114036119020338/0001140361-19-020338-index.htm
2019-11-14424B2Prospectus [Rule 424(b)(2)]https://www.sec.gov/Archives/edgar/data/882796/000114036119020642/0001140361-19-020642-index.htm
2019-11-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000114036119020752/0001140361-19-020752-index.htm
2019-11-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000114036119020989/0001140361-19-020989-index.htm
2019-11-21424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/882796/000114036119021082/0001140361-19-021082-index.htm
2019-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000114036119021088/0001140361-19-021088-index.htm
2020-04-24S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/882796/000114036120009639/0001140361-20-009639-index.htm
2020-05-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/882796/000114036120010641/0001140361-20-010641-index.htm
2020-05-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/882796/000114036120011394/0001140361-20-011394-index.htm
2020-05-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/882796/000114036120012557/0001140361-20-012557-index.htm
2020-05-29424B2Prospectus [Rule 424(b)(2)]https://www.sec.gov/Archives/edgar/data/882796/000114036120012652/0001140361-20-012652-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000114036120012787/0001140361-20-012787-index.htm
2020-06-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000114036120013520/0001140361-20-013520-index.htm
2020-06-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000114036120013521/0001140361-20-013521-index.htm
2020-06-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000114036120013522/0001140361-20-013522-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000114420419007217/0001144204-19-007217-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000114420419008282/0001144204-19-008282-index.htm
2019-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319000006/0001171843-19-000006-index.htm
2019-01-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319000126/0001171843-19-000126-index.htm
2019-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319000749/0001171843-19-000749-index.htm
2019-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319001171/0001171843-19-001171-index.htm
2019-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319001442/0001171843-19-001442-index.htm
2019-03-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/882796/000117184319001727/0001171843-19-001727-index.htm
2019-04-17DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/882796/000117184319002458/0001171843-19-002458-index.htm
2019-04-17DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/882796/000117184319002459/0001171843-19-002459-index.htm
2019-04-29S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000117184319002720/0001171843-19-002720-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319003094/0001171843-19-003094-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184319003220/0001171843-19-003220-index.htm
2019-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319003529/0001171843-19-003529-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319003812/0001171843-19-003812-index.htm
2019-06-04S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000117184319003816/0001171843-19-003816-index.htm
2019-06-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319004220/0001171843-19-004220-index.htm
2019-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319004257/0001171843-19-004257-index.htm
2019-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319004259/0001171843-19-004259-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319005182/0001171843-19-005182-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184319005326/0001171843-19-005326-index.htm
2019-09-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319005941/0001171843-19-005941-index.htm
2019-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319006063/0001171843-19-006063-index.htm
2019-09-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319006137/0001171843-19-006137-index.htm
2019-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319006859/0001171843-19-006859-index.htm
2019-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319007064/0001171843-19-007064-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319007155/0001171843-19-007155-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319007214/0001171843-19-007214-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319007363/0001171843-19-007363-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184319007384/0001171843-19-007384-index.htm
2019-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319008053/0001171843-19-008053-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320000183/0001171843-20-000183-index.htm
2020-01-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320000241/0001171843-20-000241-index.htm
2020-02-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320000650/0001171843-20-000650-index.htm
2020-02-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320001018/0001171843-20-001018-index.htm
2020-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320001229/0001171843-20-001229-index.htm
2020-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320001491/0001171843-20-001491-index.htm
2020-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320001492/0001171843-20-001492-index.htm
2020-03-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320001589/0001171843-20-001589-index.htm
2020-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/882796/000117184320001710/0001171843-20-001710-index.htm
2020-03-19PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/882796/000117184320001853/0001171843-20-001853-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320002124/0001171843-20-002124-index.htm
2020-03-31DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/882796/000117184320002184/0001171843-20-002184-index.htm
2020-03-31DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/882796/000117184320002185/0001171843-20-002185-index.htm
2020-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320002295/0001171843-20-002295-index.htm
2020-04-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320002530/0001171843-20-002530-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320003357/0001171843-20-003357-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184320003557/0001171843-20-003557-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320003680/0001171843-20-003680-index.htm
2020-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320005453/0001171843-20-005453-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320005596/0001171843-20-005596-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184320005753/0001171843-20-005753-index.htm
2020-08-12S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000117184320005862/0001171843-20-005862-index.htm
2020-08-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320006161/0001171843-20-006161-index.htm
2020-08-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320006178/0001171843-20-006178-index.htm
2020-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320006249/0001171843-20-006249-index.htm
2020-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320006729/0001171843-20-006729-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320007628/0001171843-20-007628-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184320007740/0001171843-20-007740-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000117266120000839/0001172661-20-000839-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000119380519000192/0001193805-19-000192-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000119380520000190/0001193805-20-000190-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000127417319000036/0001274173-19-000036-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000127417320000008/0001274173-20-000008-index.htm
2019-05-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000131924419000051/0001319244-19-000051-index.htm
2020-01-22SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000131924420000014/0001319244-20-000014-index.htm
2020-05-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/882796/999999999520001159/9999999995-20-001159-index.htm
2018-12-17CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/882796/999999999718009595/9999999997-18-009595-index.htm
2020-05-01CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/882796/999999999720002395/9999999997-20-002395-index.htm

BioCryst Pharmaceuticals, Inc (BCRX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of BioCryst Pharmaceuticals, Inc (BCRX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 85%
Institutional Ownership: 7395%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-12-10Lynne PowellSenior VP - CCOSell2,000.009.0118,020.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760218036067/0001127602-18-036067-index.htm
2018-12-10Lynne PowellSenior VP - CCOSell2,000.009.1118,220.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760218036067/0001127602-18-036067-index.htm
2019-01-14Lynne PowellSenior VP - CCOSell954.009.208,776.800.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002141/0001127602-19-002141-index.htm
2019-01-16Lynne PowellSenior VP - CCOSell3,046.009.2728,236.420.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002367/0001127602-19-002367-index.htm
2019-01-18Lynne PowellSenior VP - CCOSell2,000.009.4018,800.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002527/0001127602-19-002527-index.htm
2019-01-25Lynne PowellSenior VP - CCOSell6,000.009.6057,600.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2019-01-28Lynne PowellSenior VP - CCOSell4,000.009.8839,520.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2019-01-28Lynne PowellSenior VP - CCOSell2,000.009.9119,820.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2020-03-01THERESA HEGGIEDirectorBuy1,666.003.004,998.0010,092.00https://www.sec.gov/Archives/edgar/data/882796/000112760220009089/0001127602-20-009089-index.htm
2019-11-18Alane P BarnesSenior VP, Chief Legal OfficerBuy20,000.001.4529,000.00102,061.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033008/0001127602-19-033008-index.htm
2020-06-01THERESA HEGGIEDirectorBuy1,112.004.504,998.4411,204.00https://www.sec.gov/Archives/edgar/data/882796/000112760220018715/0001127602-20-018715-index.htm
2020-08-31THERESA HEGGIEDirectorBuy1,204.004.154,996.6012,408.00https://www.sec.gov/Archives/edgar/data/882796/000112760220024644/0001127602-20-024644-index.htm
2019-05-17THOMAS R II STAABSenior Vice President and CFOSell2,500.007.4518,625.00125,176.00https://www.sec.gov/Archives/edgar/data/882796/000112760219019143/0001127602-19-019143-index.htm
2019-05-16THOMAS R II STAABSenior Vice President and CFOSell7,250.007.7255,970.00127,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219019143/0001127602-19-019143-index.htm
2019-01-31Yarlagadda S BabuSenior VP - Drug DiscoveryBuy19,686.001.2023,623.20127,786.00https://www.sec.gov/Archives/edgar/data/882796/000112760219003737/0001127602-19-003737-index.htm
2019-01-28THOMAS R II STAABSenior Vice President and CFOSell5,000.009.8549,250.00128,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219003053/0001127602-19-003053-index.htm
2019-05-15THOMAS R II STAABSenior Vice President and CFOSell7,250.007.9257,420.00130,176.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm
2019-01-31Yarlagadda S BabuSenior VP - Drug DiscoveryBuy12,188.001.2014,625.60132,272.00https://www.sec.gov/Archives/edgar/data/882796/000112760219003737/0001127602-19-003737-index.htm
2019-04-04THOMAS R II STAABSenior Vice President and CFOSell7,500.008.8166,075.00132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219014988/0001127602-19-014988-index.htm
2019-05-02THOMAS R II STAABSenior Vice President and CFOSell7,750.007.3056,575.00132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm
2019-05-06THOMAS R II STAABSenior Vice President and CFOSell9,000.007.7569,750.00132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm
2019-05-09THOMAS R II STAABSenior Vice President and CFOSell9,750.007.6374,392.50132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm
2019-05-13THOMAS R II STAABSenior Vice President and CFOSell9,750.007.7675,660.00132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm
2019-05-14THOMAS R II STAABSenior Vice President and CFOSell4,500.007.6234,290.00132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm
2019-01-28THOMAS R II STAABSenior Vice President and CFOBuy5,000.005.4527,250.00133,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219003053/0001127602-19-003053-index.htm
2019-05-16THOMAS R II STAABSenior Vice President and CFOBuy4,750.001.426,745.00134,926.00https://www.sec.gov/Archives/edgar/data/882796/000112760219019143/0001127602-19-019143-index.htm
2019-05-14THOMAS R II STAABSenior Vice President and CFOBuy4,500.001.426,390.00137,176.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm
2019-05-15THOMAS R II STAABSenior Vice President and CFOBuy4,750.001.426,745.00137,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm
2019-04-04THOMAS R II STAABSenior Vice President and CFOBuy7,500.005.5141,325.00140,176.00https://www.sec.gov/Archives/edgar/data/882796/000112760219014988/0001127602-19-014988-index.htm
2019-05-02THOMAS R II STAABSenior Vice President and CFOBuy7,750.005.5142,702.50140,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm
2019-05-06THOMAS R II STAABSenior Vice President and CFOBuy9,000.005.5149,590.00141,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm
2019-05-09THOMAS R II STAABSenior Vice President and CFOBuy9,750.005.5153,722.50142,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm
2019-05-13THOMAS R II STAABSenior Vice President and CFOBuy9,750.005.5153,722.50142,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm
2019-11-18KENNETH B JR LEEDirectorBuy5,000.001.457,250.0015,252.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033029/0001127602-19-033029-index.htm
2019-11-18Yarlagadda S BabuSenior VP - Drug DiscoveryBuy25,000.001.4536,250.00155,587.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033004/0001127602-19-033004-index.htm
2019-09-01THERESA HEGGIEDirectorBuy1,672.002.994,999.281,672.00https://www.sec.gov/Archives/edgar/data/882796/000112760219027871/0001127602-19-027871-index.htm
2018-12-10Lynne PowellSenior VP - CCOBuy2,000.003.226,440.002,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760218036067/0001127602-18-036067-index.htm
2019-01-18Lynne PowellSenior VP - CCOBuy2,000.003.226,440.002,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002527/0001127602-19-002527-index.htm
2019-01-28Lynne PowellSenior VP - CCOBuy2,000.003.226,440.002,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2019-03-12STEVE ASELAGEDirectorBuy2,000.008.3016,600.002,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219011361/0001127602-19-011361-index.htm
2019-11-18STEVE ASELAGEDirectorBuy15,000.001.4521,750.0021,672.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033001/0001127602-19-033001-index.htm
2019-12-01STEVE ASELAGEDirectorBuy1,754.002.854,998.9023,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219034168/0001127602-19-034168-index.htm
2020-03-01STEVE ASELAGEDirectorBuy1,666.003.004,998.0025,092.00https://www.sec.gov/Archives/edgar/data/882796/000112760220009094/0001127602-20-009094-index.htm
2020-06-01STEVE ASELAGEDirectorBuy1,112.004.504,998.4426,204.00https://www.sec.gov/Archives/edgar/data/882796/000112760220018719/0001127602-20-018719-index.htm
2018-12-18William P SheridanSenior VP - CMOSell20,488.007.58155,299.042,725.00https://www.sec.gov/Archives/edgar/data/882796/000112760218036977/0001127602-18-036977-index.htm
2019-09-01ROBERT ALEXANDER INGRAMDirectorBuy6,270.002.9918,747.3028,088.00https://www.sec.gov/Archives/edgar/data/882796/000112760219027858/0001127602-19-027858-index.htm
2020-08-31STEVE ASELAGEDirectorBuy2,409.004.159,997.3528,613.00https://www.sec.gov/Archives/edgar/data/882796/000112760220024642/0001127602-20-024642-index.htm
2019-01-16Lynne PowellSenior VP - CCOBuy3,046.003.229,808.123,046.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002367/0001127602-19-002367-index.htm
2019-01-28Lynne PowellSenior VP - CCOBuy4,000.003.2212,880.004,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2019-09-01Nancy J HutsonDirectorBuy3,344.002.999,998.5643,046.00https://www.sec.gov/Archives/edgar/data/882796/000112760219027862/0001127602-19-027862-index.htm
2019-11-18Megan SniecinskiChief Business OfficerBuy45,000.001.4565,250.0045,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033033/0001127602-19-033033-index.htm
2019-11-18ROBERT ALEXANDER INGRAMDirectorBuy20,000.001.4529,000.0048,088.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033025/0001127602-19-033025-index.htm
2019-05-22STEVE ASELAGEDirectorBuy3,000.003.5710,710.005,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219019891/0001127602-19-019891-index.htm
2019-11-18Nancy J HutsonDirectorBuy10,000.001.4514,500.0053,046.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033022/0001127602-19-033022-index.htm
2020-08-11Anthony DoyleChief Financial OfficerBuy54,000.004.08220,320.0054,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760220023449/0001127602-20-023449-index.htm
2019-12-01ROBERT ALEXANDER INGRAMDirectorBuy6,578.002.8518,747.3054,666.00https://www.sec.gov/Archives/edgar/data/882796/000112760219034162/0001127602-19-034162-index.htm
2019-12-01Nancy J HutsonDirectorBuy3,508.002.859,997.8056,554.00https://www.sec.gov/Archives/edgar/data/882796/000112760219034165/0001127602-19-034165-index.htm
2020-03-01Nancy J HutsonDirectorBuy3,333.003.009,999.0059,887.00https://www.sec.gov/Archives/edgar/data/882796/000112760220009065/0001127602-20-009065-index.htm
2019-01-25Lynne PowellSenior VP - CCOBuy6,000.003.2219,320.006,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2020-03-01ROBERT ALEXANDER INGRAMDirectorBuy6,250.003.0018,750.0060,916.00https://www.sec.gov/Archives/edgar/data/882796/000112760220009058/0001127602-20-009058-index.htm
2020-06-01Nancy J HutsonDirectorBuy2,224.004.509,996.8862,111.00https://www.sec.gov/Archives/edgar/data/882796/000112760220018711/0001127602-20-018711-index.htm
2020-08-31Nancy J HutsonDirectorBuy1,204.004.154,996.6063,315.00https://www.sec.gov/Archives/edgar/data/882796/000112760220024646/0001127602-20-024646-index.htm
2020-06-01ROBERT ALEXANDER INGRAMDirectorBuy4,171.004.5018,748.6565,087.00https://www.sec.gov/Archives/edgar/data/882796/000112760220018704/0001127602-20-018704-index.htm
2019-09-01STEVE ASELAGEDirectorBuy1,672.002.994,999.286,672.00https://www.sec.gov/Archives/edgar/data/882796/000112760219027867/0001127602-19-027867-index.htm
2019-11-18THERESA HEGGIEDirectorBuy5,000.001.457,250.006,672.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033017/0001127602-19-033017-index.htm
2020-08-31ROBERT ALEXANDER INGRAMDirectorBuy4,518.004.1518,749.7069,605.00https://www.sec.gov/Archives/edgar/data/882796/000112760220024637/0001127602-20-024637-index.htm
2019-11-18Jon P StonehousePresident & CEOBuy50,000.001.4572,500.00778,086.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033035/0001127602-19-033035-index.htm
2019-12-01THERESA HEGGIEDirectorBuy1,754.002.854,998.908,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219034170/0001127602-19-034170-index.htm
2019-01-14Lynne PowellSenior VP - CCOBuy954.003.223,071.88954.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002141/0001127602-19-002141-index.htm